Trials / Completed
CompletedNCT00662558
A Six Week Study Of The Pain Relieving Effects Of Celecoxib 200 Mg Twice Daily Compared To Tramadol 50 Mg Four Times Daily In Patients With Chronic Low Back Pain
A Six Week Double-Blind, Randomized, Multicenter Comparison Study Of The Analgesic Effectiveness Of Celecoxib 200 Mg BID Compared To Tramadol Hydrochloride 50 Mg QID In Subjects With Chronic Low Back Pain
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 802 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To compare the analgesic effectiveness of celecoxib and tramadol in subjects with Chronic Low Back Pain measured by the Numerical Rating Scale (NRS-Pain) at Week 6
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | celecoxib | 200 mg capsules BID for 6 weeks |
| DRUG | tramadol HCL | 50 mg capsules QID for 6 weeks |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2008-09-01
- Completion
- 2008-09-01
- First posted
- 2008-04-21
- Last updated
- 2021-02-21
- Results posted
- 2009-11-23
Locations
60 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00662558. Inclusion in this directory is not an endorsement.